Mode
Text Size
Log in / Sign up
Phase 2 N=118 Randomized Single-blind Treatment

Internet-based Treatment for Chronic Insomnia

Insomnia · Insomnia Disorder

Enrolled (actual)
118
Serious AEs
0.0%
Results posted
Sep 2011
Primary outcome: Primary: Sleep Quality — 1.77; 2.18 0-4 scale of sleep quality

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Cognitive Behavioral Therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Manitoba
Primary completion
Jan 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Sleep Quality
1.77; 2.18
SECONDARY
Pre-Sleep Arousal
25.46; 22.42
SECONDARY
Beliefs and Attitudes About Sleep

Summary

Study Objectives. Despite effective cognitive behavioral treatments for chronic insomnia, such treatments are underutilized. This study evaluates the impact of a 6-week, online treatment for insomnia. Design This is a randomized controlled trial with online treatment and waiting list control conditions. Participants Participants are adults in Manitoba Canada with chronic insomnia. Setting Participants receive online treatment from their homes. Intervention. Online treatment consists of psychoeducation, sleep hygiene and stimulus control instruction, sleep restriction treatment, mindfulness training, relaxation training, cognitive therapy, and help with medication tapering. Measurement and Results. The impact of online treatment on primary end points of sleep quality, insomnia severity, and daytime fatigue will be assessed.

Eligibility Criteria

Inclusion Criteria

  • Access to high speed internet, insomnia duration > 6 months and occurring at least 4 nights per week, sleep-onset latency > 30 minutes and/or time awake at night > 30 minutes, and/or early morning awakening > 30 minutes before desired time, at least one type of daytime impairment.

Exclusion Criteria

  • Shift work, acute suicidality, mania, schizophrenia, head injury, alcohol intake > 14 drinks/week for males, > 12 drinks per week for females, current or past behavioral treatment for insomnia
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00821041). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search